tirzepatide protein antidiabetic drug action, illustration - Stock Image - C059/5020 RCSB PDB - 7FIM: Cryo-EM

Continuous forever is the single option the evidence actively cant back, and the convenience gained from it doesnt come close to justifying the unknowns it takes on

Research emphasizes sustained cellular balance rather than short-term stimulation

doru dozlarda gvenli olduu bilimsel olarak kantlanmtr

Which is why the use of GLP-1 therapy could be a gamechanger

Hogan and colleagues, St Vincents University Hospital, University College Dublin, Ireland, in a paper just published in Diabetologia , now report improvement of psoriasis in three obese patients with type 2 diabetes several weeks after the initiation of therapy with the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists exenatide and liraglutide